Boris Quednow

Boris B. Quednow, Prof. Dr. rer. nat.

Coordinator Center for Psychatric Research
Group Leader

Phone: +41 (0)58 384 27 77

E-Mail

Curriculum vitae

Boris B. Quednow studied psychology and pharmacy at the University of Bonn. He wrote his dissertation on the neurobiological consequences of ecstasy (MDMA) use at the Ruhr-University of Bochum and worked as a research assistant at the Department of Psychiatry of the University of Bonn. At present, he is Associate Professor at the Department for Psychiatry, Psychotherapy and Psychosomatics at the Psychiatric Hospital of the University of Zurich. His main research interests are the behavioral neurotoxicology and neuroplasticity of illegal drug use, the neurochemistry of sensorimotor gating and higher cognitive functions, behavioral genetics, and disturbed information processing in psychiatric diseases, particularly in schizophrenia and drug addiction.

Complete Publication List

ORCID: https://orcid.org/0000-0001-7933-2865

Publications in ZORA:

ZORA Publication List

Download Options

Format for Download Link

Download asCSV Download asRIS Download asBIBTEX

Publications

Xia, Y., Quednow, B. B., & Bach, D. R. (2026). A systematic review of pharmacological effects on human aversive memory Neuroscience and Biobehavioral Reviews, 183, 106548. https://doi.org/10.1016/j.neubiorev.2026.106548
Eggenberger, L., Janousch, C., Johnson-Ferguson, L., Baumgartner, M., Binz, T. M., Ribeaud, D., Eisner, M., Shanahan, L., & Quednow, B. B. (2026). Something is not nothing: Hair-tested substance use and cognitive functions in a large community sample of young adults European Psychiatry, 1–30. https://doi.org/10.1192/j.eurpsy.2026.10156
Janousch, C., Vock, F., Winter, B., Hässler, T., Eggenberger, L., Bechtiger, L., Loher, M., Binz, T. M., Baumgartner, M. R., Ribeaud, D., Eisner, M., Quednow, B. B., & Shanahan, L. (2026). How do substance and polysubstance use trajectories differ by sexual attraction from ages 17 to 24? A community-based longitudinal cohort study in Switzerland BMJ Public Health, 4(1), e003583. https://doi.org/10.1136/bmjph-2025-003583
Janousch, C., Grob, U., Eggenberger, L., Johnson-Ferguson, L., Ribeaud, D., Eisner, M., Shanahan, L., & Quednow, B. B. (2025). A Fine-Grained Longitudinal Study of Adolescent Cannabis Use and Its Relation to Cognitive Performance in Young Adulthood International Journal of Mental Health and Addiction, online. https://doi.org/10.1007/s11469-025-01604-0
Schleim, S., & Quednow, B. B. (2025). What challenges remain after 25 years of the enhancement debate? Physics of Life Reviews, 55, 210–212. https://doi.org/10.1016/j.plrev.2025.10.004
Gasparovic, L., Burden, A. M., Senn, O., Markun, S., Quednow, B. B., Neuner-Jehle, S., Stammschulte, T., & Weiler, S. (2025). Age disparities in adverse reactions of drugs used in pain therapies in Switzerland Scientific Reports, 15(1), 45301. https://doi.org/10.1038/s41598-025-28959-7
Loher, M., Jang, J. B., Quednow, B. B., Shanahan, L., & Patrick, M. (2025). Concurrent Alcohol and Marijuana Use Patterns Among High School Seniors in the United States Journal of Drug Issues, Epub ahead print. https://doi.org/10.1177/00220426251394640
Schmid, V. K., Quednow, B. B., Pellegata, D., Meier, P., Gertsch, J., & Kroll, S. (2025). Endocannabinoid response to social stress in chronic non-medical prescription opioid users Psychopharmacology, 243(2), 427–441. https://doi.org/10.1007/s00213-025-06950-4
Coray, R. C., Beliveau, V., Zimmermann, J., Preller, K. H., Wunderli, M., Baumgartner, M. R., Seifritz, E., Stock, A.-K., Beste, C., Cole, D. M., & Quednow, B. B. (2025). Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities Brain, Epub ahead of print. https://doi.org/10.1093/brain/awaf391
Johnson-Ferguson, L., Loher, M., Bechtiger, L., Janousch, C., Baumgartner, M. R., Binz, T. M., Ribeaud, D., Eisner, M., Quednow, B. B., & Shanahan, L. (2025). Cannabis use is associated with changes in psychological and functional well-being during young adulthood: evidence from self-reports and hair analyses Psychological Medicine, 55, e246. https://doi.org/10.1017/s003329172510144x
Grison, Simon; Johnson-Ferguson, Lydia; Vonmoos, Matthias; Baumgartner, Markus R; Quednow, Boris B (2025). Associations Between Self‐Reported Cocaine Use Patterns and Cocaine and Its Metabolites in Hair: Implications for Clinical and Forensic Practices Drug Testing and Analysis, 17(8):1186-1195.
Gholamipourbarogh, N., Opitz, A., Jamous, R., Zimmermann, J., Cole, D., Quednow, B. B., Stock, A.-K., & Beste, C. (2025). Tracking the cortical processing pathway of representational contents during emotional conflicts Journal of Neurophysiology, 134(2), 628–641. https://doi.org/10.1152/jn.00163.2025
Quednow, B. B., & Dürsteler, K. (2025). Amphetamine und Crystal Meth: Epidemiologie, Symptomatik und Therapie konsumassoziierter Störungen Suchttherapie, 26(03), 152–165. https://doi.org/10.1055/a-2451-0277
Bavato, Francesco; Schnider, Laura K; Dornbierer, Dario A; Di Floriano, Julia R; Stucky, Benjamin; Friedli, Nicole; Janki, Marina; Quednow, Boris B; Landolt, Hans-Peter; Bosch, Oliver G; Seifritz, Erich (2025). Gamma-hydroxybutyrate to promote slow-wave sleep in major depressive disorder: a randomized crossover trial Neuropsychopharmacology, 50(8):1237-1244.
Kronenberg, G., Bankwitz, A., Provaznikova, B., Müller, M., Quednow, B. B., Seifritz, E., & Olbrich, S. (2025). Inhalational nitrous oxide as a transdiagnostic approach for the treatment of suicidal ideation and suicidality in psychiatric inpatients: protocol for a double-blind randomised, controlled clinical single-centre trial BMJ Open, 15(7), e096825. https://doi.org/10.1136/bmjopen-2024-096825
Mahlberg, J., Hanegraaf, L., Zimmermann, J., Cole, D. M., Quednow, B. B., Arunogiri, S., & Verdejo‐Garcia, A. (2025). Social cognition and decision‐making in people with methamphetamine use disorder Addiction, 120(10), 2020–2031. https://doi.org/10.1111/add.70108
Egger, Klemens . Neurobehavioral and Molecular Pharmacology of Pharmahuasca ($\textit{N,N}$-dimethyltryptamine (DMT) and Harmine) in Humans – A Combined Neuropharmacological and Brain Imaging Approach 2025, University of Zurich, Mathematisch-naturwissenschaftliche Fakultät.
Bavato, F., & Quednow, B. B. (2025). Ketamine addiction in Europe: Any risks on the horizons? European Neuropsychopharmacology, 94, 39–40. https://doi.org/10.1016/j.euroneuro.2025.02.015
Berberat, J., Kagerer, S. M., Späni, C., Hua, J., Bavato, F., Gruber, P., van Zijl, P. C., Perroud, N., Li, X., Stämpfli, P., Seifritz, E., Lövblad, K.-O., Quednow, B. B., & Unschuld, P. G. (2025). Brain iron load and neuroaxonal vulnerability in adult attention-deficit hyperactivity disorder Psychiatry and Clinical Neurosciences, 79(5), 282–289. https://doi.org/10.1111/pcn.13806
Loher, Michelle; Steinhoff, Annekatrin; Bechtiger, Laura; Ribeaud, Denis; Eisner, Manuel; Shanahan, Lilly; Quednow, Boris B (2025). Disentangling the effects of self-control and the use of tobacco and cannabis on violence perpetration from childhood to early adulthood European Child & Adolescent Psychiatry, 34(3):1063-1074.

Quicklinks

Main navigation